Chronic widespread pain in spondyloarthritis

Reumatismo

Volumn 66, Issue 1, 2014, Pages 28-32

  Atzeni, Fabiola ^a   Boccassini, L ^a   Di Franco, M ^b   Alciati, A ^c   Marsico, A ^d   Cazzola, M ^e   Cassisi, G ^f   Sarzi Puttini, P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Hermanas Hospitalarias FoRiPsi Department of Clinic Neurosciences ^*  (Italy)

^d SS Annunziata Hospital   (Italy)

^e Unit of Rehabilitation Medicine   (Italy)

^f Rheumatology Branch   (Italy)

Author keywords

Ankylosing spondylitis disease activity score; Bath ankylosing spondylitis disease activity index; Disease activity; Fibromyalgia; Prevalence; Spondyloarthritis

Indexed keywords

AMITRIPTYLINE; DULOXETINE; FLUOXETINE; MILNACIPRAN; TUMOR NECROSIS FACTOR INHIBITOR; VENLAFAXINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIA; ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE; ANKYLOSING SPONDYLITIS QUALITY OF LIFE SCORE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; BATH ANKYLOSING SPONDYLITIS RADIOLOGY INDEX; CHRONIC PAIN; CHRONIC WIDESPREAD PAIN; DISEASE ASSOCIATION; FIBROMYALGIA; HUMAN; PAIN ASSESSMENT; PSORIATIC ARTHRITIS; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SPONDYLARTHRITIS; ARTHRITIS, PSORIATIC; CENTRAL NERVOUS SYSTEM SENSITIZATION; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; ECONOMICS; FATIGUE; MUSCULOSKELETAL PAIN; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SLEEP DISORDERS, INTRINSIC;

ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CENTRAL NERVOUS SYSTEM SENSITIZATION; CHRONIC PAIN; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FATIGUE; FIBROMYALGIA; HUMANS; MUSCULOSKELETAL PAIN; PAIN MANAGEMENT; PAIN MEASUREMENT; QUALITY OF LIFE; SLEEP DISORDERS, INTRINSIC; SPONDYLARTHRITIS;

EID: 84902202670     PISSN: 00487449     EISSN: 22402683     Source Type: Journal    
DOI: 10.4081/reumatismo.2014.761     Document Type: Review

References (47)

1. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007; 369: 1379-90.
2. Gladman DD. Clinical aspects of the spondyloarthropathies. Am J Med Sci. 1988; 3: 234-8.
3. Van Der Linden S, Van Der Heijde D. Ankylosing spondylitis: clinical features. Rheum Dis Clin North Am. 1998; 24: 663-76.
4. Kazis LE, Meenan RF, Anderson JJ. Pain in the rheumatic diseases. Investigation of a key health status component. Arthritis Rheum. 1983; 26: 1017-22.
5. Atzeni F, Cazzola M, Benucci M, Di Franco M, Salaffi F, Sarzi-Puttini P. Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol. 2011; 25: 165-71.
6. Dhondt W, Willaeys T, Verbruggen LA, Oostendorp RA, Duquet W. Pain threshold in patients with rheumatoid arthritis and effect of manual oscillations. Scand J Rheumatol. 1999; 28: 88-93.
7. Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford). 2012; 51: 1416-25.
8. Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rheumatol. 2007; 34: 1674-83.
9. Lee YC, Cui J, Lu B, Frits ML, Iannaccone CK, Shadick NA, et al. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/ EULAR remission: a longitudinal observational study. Arthritis Res Ther. 2011; 13: R83.
10. Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states-maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011; 25: 141-54.
11. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2010; 152: S2-15.
12. Incel NA, Erdem HR, Ozgocmen S, Catal SA, Yorgancioglu ZR. Pain pressure threshold values in ankylosing spondylitis. Rheumatol Int. 2002; 22: 148-50.
13. Konno T. Differentiation of the clinical features of psoriatic arthritis and fibromyalgia. J Rheumatol. 2012; 39: 11.
14. Fitzcharles MA, Boulos P. Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology. 2003; 42: 263-7.
15. Salaffi F, Sarzi-Puttini P, Ciapetti A, Atzeni F. Clinimetric evaluations of patients with chronic widespread pain. Best Pract Res Clin Rheumatol. 2011; 25: 249-70.
16. Salaffi F, Sarzi-Puttini P, Ciapetti A, Atzeni F. Assessment instruments for patients with fibromyalgia: properties, applications and interpretation. Clin Exp Rheumatol. 2009; 27: S92-105.
17. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33: 160-72.
18. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010; 62: 600-10.
19. Salaffi F, Sarzi-Puttini P. Old and new criteria for the classification and diagnosis of fibromyalgia: comparison and evaluation. Clin Exp Rheumatol. 2012; 30: 3-9.
20. Sieper J. How to define remission in ankylosing spondylitis? Ann Rheum Dis. 2012; 71: i93-5.
21. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002; 136: 896-907.
22. Cazzola M, Sarzi-Puttini P, Stisi S, Di Franco M, Bazzichi L, Carignola L, et al. Fibromyalgia syndrome: definition and diagnostic aspects. Reumatismo. 2008; 60: 3-14.
23. Heikkila S, Ronni S, Kautiainen HJ, Kauppi MJ. Functional impairment in spondyloarthropathy and fibromyalgia. J Rheumatol. 2002; 29: 1415-9.
24. Gutierrez M, Di Geso L, Salaffi F, Bertolazzi C, Tardella M, Filosa G, et al. Development of a preliminary US power Doppler composite score for monitoring treatment in PsA. Rheumatology (Oxford). 2012; 51: 1261-8.
25. Gutierrez M, Luccioli F, Salaffi F, Bartoloni E, Bertolazzi C, Bini V, et al. Ultrasound revealing subclinical enthesopathy at the greater trochanter level in patients with spondyloarthritis. Clin Rheumatol. 2012; 31: 463-8.
26. Gutierrez M, Filippucci E, Salaffi F, Di Geso L, Grassi W. Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level. Ann Rheum Dis. 2011; 70: 1111-4.
27. Coates LC, Mumtaz A, Helliwell PS, Mease PJ, Callis-Duffin K, Krueger GG, et al. Development of a disease severity and responder index for psoriatic arthritis (PsA)-report of the OMERACT 10 PsA special interest group. J Rheumatol. 2011; 38: 1496-501.
28. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009; 68: ii1-44.
29. Slobodin G, Reyhan I, Avshovich N, Balbir-Gurman A, Boulman N, Elias M, et al. Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosis. Clin Rheumatol. 2011; 30: 1075-80.
30. Aloush V, Ablin JN, Reitblat T, Caspi D, Elkayam O. Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int. 2007; 27: 865-8.
31. Azevedo VF, Paiva Edos S, Felippe LR, Moreira RA. Occurrence of fibromyalgia in patients with ankylosing spondylitis. Rev Bras Reumatol. 2010; 50: 646-50.
32. Almodóvar R, Carmona L, Zarco P, Collantes E, González C, Mulero J, et al. Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol. 2010; 28: S33-9.
33. Salaffi F, De Angelis R, Carotti M, Gutierrez M, Sarzi-Puttini P, Atzeni F. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int. 2014. [Epub ahead of print].
34. Atzeni F, Beasly M, Dean L, Jones G, Sarzi-Puttini P, Macfarlane G. Do patients with ankylosing spondylitis have an excess prevalence of chronic widespread pain? Results from the Scotland and Ireland Registry for Ankylosing Spondylitis (SIRAS) and the MUSICIAN study. [Abstract]. Arthritis Rheum. 2013; 65: 1536.
35. Atzeni F, Ventura D, Batticciotto A, Boccassini L, Sarzi-Puttini P. Interleukin 6 blockade: tocilizumab in psoriatic arthritis. J Rheumatol. 2012; 89: 97-9.
36. Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe HA. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol. 1992; 19: 1115-9.
37. Marchesoni A, Atzeni F, Spadaro A, Lubrano E, Provenzano G, Cauli A, et al. Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol. 2012; 39: 849-55.
38. Mas AJ, Carmona LM, Valverde M, Ribas B; the EPISER Study Group. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol. 2008; 26: 519-26.
39. Hughes G, Martinez C, Myon E, Tai{dotless} C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum. 2006; 54: 177-83.
40. Kivimäki M, Leino-Arjas P, Kaila-Kangas L, Virtanen M, Elovainio M, Puttonen S, et al. Increased sickness absence among employees with fibromyalgia. Ann Rheum Dis. 2007; 66: 65-9.
41. Ofluoglu D, Berker N, Güven Z, Canbulat N, Yilmaz IT, Kayhan O. Quality of life in patients with fibromyalgia syndrome and rheumatoid arthritis. Clin Rheumatol. 2005; 24: 490-2.
42. Hawley DJ, Wolfe F. Pain, disability, and pain/ disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol. 1991; 18: 1552-7.
43. Verbunt JA, Pernot DHFM, Smeets RJEM. Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes. 2008; 6: 8.
44. Perrot S, Schaefer C, Knight T, Hufstader M, Chandran AB, Zlateva G. Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains. BMC Musculoskeletal Dis. 2012; 13: 22.
45. Aydin SZ, Can M, Atagunduz P, Direskeneli H. Active disease requiring TNF-alpha antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis. Clin Exp Rheumatol. 2010; 28: 752-5.
46. Sarzi-Puttini P, Buskila D, Carrabba M, Doria A, Atzeni F. Treatment strategy in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum. 2008; 37: 353-65.
47. Sarzi-Puttini P, Atzeni F, Salaffi F, Cazzola M, Benucci M, Mease PJ. Multidisciplinary approach to fibromyalgia: what is the teaching? Best Pract Res Clin Rheumatol. 2011; 25: 311-9.